
Affimed N.V. AFMD
Quartalsbericht 2022-Q2
hinzugefügt 11.08.2022
Affimed N.V. Finanzkreislauf 2011-2026 | AFMD
Finanzkreislauf Jährlich Affimed N.V.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -2.42 K | -2.91 K | -1.25 K | -1.69 K | -1.66 K | -1.47 K | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -1.25 K | -2.91 K | -1.9 K |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Aquestive Therapeutics
AQST
|
-172 | $ 3.88 | -1.27 % | $ 415 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
205 | $ 19.23 | - | $ 899 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
AgeX Therapeutics
AGE
|
-8.96 K | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
-54.4 | - | - | $ 546 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Cara Therapeutics
CARA
|
52.4 | - | -3.03 % | $ 260 M | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
130 | $ 0.71 | 17.15 % | $ 8.13 M | ||
|
CytomX Therapeutics
CTMX
|
12.2 | $ 4.24 | -4.83 % | $ 585 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
-1.6 K | - | -5.98 % | $ 34.1 M | ||
|
ChemoCentryx
CCXI
|
3.1 | - | - | $ 3.74 B | ||
|
Aytu BioScience
AYTU
|
174 | $ 2.65 | 0.76 % | $ 16.6 M | ||
|
Dynavax Technologies Corporation
DVAX
|
459 | - | - | $ 2.02 B | ||
|
BioDelivery Sciences International
BDSI
|
340 | - | -4.8 % | $ 255 M | ||
|
Eton Pharmaceuticals
ETON
|
115 | $ 22.97 | -3.53 % | $ 618 M | ||
|
Exelixis
EXEL
|
-8.32 | $ 41.57 | 0.39 % | $ 11.3 B | ||
|
Fortress Biotech
FBIO
|
-285 | $ 2.92 | -2.01 % | $ 60.7 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
50 | $ 4.31 | -2.49 % | $ 826 M |